Annual Retained Earnings:
-$1.80B-$465.89M(-34.86%)Summary
- As of today, MDGL annual retained earnings is -$1.80 billion, with the most recent change of -$465.89 million (-34.86%) on December 31, 2024.
- During the last 3 years, MDGL annual retained earnings has fallen by -$1.13 billion (-170.07%).
- MDGL annual retained earnings is now -4822.25% below its all-time high of -$36.61 million, reached on December 31, 2002.
Performance
MDGL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$1.92B-$42.28M(-2.25%)Summary
- As of today, MDGL quarterly retained earnings is -$1.92 billion, with the most recent change of -$42.28 million (-2.25%) on June 30, 2025.
- Over the past year, MDGL quarterly retained earnings has dropped by -$281.90 million (-17.23%).
- MDGL quarterly retained earnings is now -3820.11% below its all-time high of -$48.92 million, reached on December 31, 2015.
Performance
MDGL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MDGL Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -34.9% | -17.2% |
| 3Y3 Years | -170.1% | -141.1% |
| 5Y5 Years | -707.4% | -521.9% |
MDGL Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -170.1% | at low | -118.7% | at low |
| 5Y | 5-Year | -707.4% | at low | -423.5% | at low |
| All-Time | All-Time | -4822.3% | at low | -3820.1% | at low |
MDGL Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$1.92B(-2.3%) |
| Mar 2025 | - | -$1.88B(-4.1%) |
| Dec 2024 | -$1.80B(-34.9%) | -$1.80B(-3.4%) |
| Sep 2024 | - | -$1.74B(-6.5%) |
| Jun 2024 | - | -$1.64B(-10.2%) |
| Mar 2024 | - | -$1.48B(-11.0%) |
| Dec 2023 | -$1.34B(-38.8%) | -$1.34B(-9.2%) |
| Sep 2023 | - | -$1.22B(-8.8%) |
| Jun 2023 | - | -$1.13B(-8.3%) |
| Mar 2023 | - | -$1.04B(-8.0%) |
| Dec 2022 | -$962.66M(-44.3%) | -$962.66M(-9.8%) |
| Sep 2022 | - | -$876.75M(-10.2%) |
| Jun 2022 | - | -$795.56M(-9.8%) |
| Mar 2022 | - | -$724.83M(-8.6%) |
| Dec 2021 | -$667.31M(-56.8%) | -$667.31M(-10.7%) |
| Sep 2021 | - | -$602.76M(-11.7%) |
| Jun 2021 | - | -$539.66M(-12.9%) |
| Mar 2021 | - | -$478.01M(-12.4%) |
| Dec 2020 | -$425.46M(-90.6%) | -$425.46M(-16.1%) |
| Sep 2020 | - | -$366.34M(-18.8%) |
| Jun 2020 | - | -$308.38M(-18.9%) |
| Mar 2020 | - | -$259.36M(-16.2%) |
| Dec 2019 | -$223.22M(-60.3%) | -$223.22M(-14.2%) |
| Sep 2019 | - | -$195.48M(-12.3%) |
| Jun 2019 | - | -$174.05M(-12.8%) |
| Mar 2019 | - | -$154.35M(-10.8%) |
| Dec 2018 | -$139.27M(-30.8%) | -$139.27M(-9.0%) |
| Sep 2018 | - | -$127.80M(-7.1%) |
| Jun 2018 | - | -$119.28M(-5.7%) |
| Mar 2018 | - | -$112.83M(-6.0%) |
| Dec 2017 | -$106.46M(-41.4%) | -$106.46M(-8.6%) |
| Sep 2017 | - | -$98.02M(-9.3%) |
| Jun 2017 | - | -$89.65M(-10.3%) |
| Mar 2017 | - | -$81.31M(-8.0%) |
| Dec 2016 | -$75.31M(-53.9%) | -$75.31M(-11.5%) |
| Sep 2016 | - | -$67.56M(+90.6%) |
| Jun 2016 | - | -$716.15M(-0.5%) |
| Mar 2016 | - | -$712.77M(-1357.0%) |
| Dec 2015 | -$48.92M | -$48.92M(+93.0%) |
| Sep 2015 | - | -$695.71M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -$678.08M(-3.0%) |
| Mar 2015 | - | -$658.28M(-3.2%) |
| Dec 2014 | -$637.57M(-15.6%) | -$637.57M(-3.3%) |
| Sep 2014 | - | -$617.22M(-3.3%) |
| Jun 2014 | - | -$597.25M(-3.9%) |
| Mar 2014 | - | -$574.97M(-4.3%) |
| Dec 2013 | -$551.41M(-19.6%) | -$551.41M(-4.6%) |
| Sep 2013 | - | -$527.25M(-4.5%) |
| Jun 2013 | - | -$504.74M(-4.7%) |
| Mar 2013 | - | -$481.95M(-4.5%) |
| Dec 2012 | -$461.22M(-15.8%) | -$461.22M(-4.1%) |
| Sep 2012 | - | -$443.10M(-3.5%) |
| Jun 2012 | - | -$428.10M(-3.5%) |
| Mar 2012 | - | -$413.48M(-3.8%) |
| Dec 2011 | -$398.43M(-13.5%) | -$398.43M(-2.8%) |
| Sep 2011 | - | -$387.69M(-3.4%) |
| Jun 2011 | - | -$374.95M(-3.4%) |
| Mar 2011 | - | -$362.45M(-3.2%) |
| Dec 2010 | -$351.05M(-11.9%) | -$351.05M(-2.6%) |
| Sep 2010 | - | -$342.23M(-3.1%) |
| Jun 2010 | - | -$331.96M(-2.8%) |
| Mar 2010 | - | -$322.89M(-3.0%) |
| Dec 2009 | -$313.58M(+20.1%) | -$313.58M(-2.3%) |
| Sep 2009 | - | -$306.55M(+27.8%) |
| Jun 2009 | - | -$424.67M(-2.0%) |
| Mar 2009 | - | -$416.17M(-6.0%) |
| Dec 2008 | -$392.67M(-30.9%) | -$392.67M(-7.1%) |
| Sep 2008 | - | -$366.72M(-7.7%) |
| Jun 2008 | - | -$340.40M(-7.1%) |
| Mar 2008 | - | -$317.70M(-5.9%) |
| Dec 2007 | -$300.05M(-26.8%) | -$300.05M(-5.5%) |
| Sep 2007 | - | -$284.53M(-5.5%) |
| Jun 2007 | - | -$269.65M(-6.6%) |
| Mar 2007 | - | -$252.91M(-6.9%) |
| Dec 2006 | -$236.56M(-31.9%) | -$236.56M(-5.6%) |
| Sep 2006 | - | -$224.07M(-25.0%) |
| Dec 2005 | -$179.29M(-62.4%) | -$179.29M(-39.8%) |
| Mar 2005 | - | -$128.28M |
| Dec 2004 | -$110.42M(-71.2%) | - |
| Dec 2003 | -$64.49M(-76.1%) | - |
| Dec 2002 | -$36.61M | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of MDGL is -$1.80B
What is the all-time high annual retained earnings for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual retained earnings is -$36.61M
What is Madrigal Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, MDGL annual retained earnings has changed by -$465.89M (-34.86%)
What is Madrigal Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of MDGL is -$1.92B
What is the all-time high quarterly retained earnings for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$48.92M
What is Madrigal Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, MDGL quarterly retained earnings has changed by -$281.90M (-17.23%)